019170.KS - Shin Poong Pharm.Co.,Ltd.

KSE - KSE Delayed Price. Currency in KRW
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-184,998,400.35194,147,337.5195,950,486.36
Cost of Revenue-104,892,984.71106,261,205.61109,362,361.28
Gross Profit-80,105,415.6487,886,131.8986,588,125.08
Operating Expenses
Research Development-4,625,7186,386,4569,136,637
Selling General and Administrative-58,692,110.8162,211,084.0866,488,970.84
Non Recurring----
Others-366,4863,202,280508,887
Total Operating Expenses-175,972,427.52184,578,869.69191,714,877.12
Operating Income or Loss-9,025,972.839,568,467.814,235,609.24
Income from Continuing Operations
Total Other Income/Expenses Net--6,113,806.37-13,271,632.53-2,070,132.19
Earnings Before Interest and Taxes-9,025,972.839,568,467.814,235,609.24
Interest Expense--4,478,276-5,358,686-6,543,387
Income Before Tax-2,912,166.46-3,703,164.722,165,477.05
Income Tax Expense-780,744.4514,895,066.03688,798.61
Minority Interest-299,600.94303,455.4304,887.61
Net Income From Continuing Ops-2,131,422.01-18,598,230.751,476,678.44
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,116,132.25-18,591,697.471,476,216.53
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,031,812.25-18,591,697.471,476,216.53